Barbara Leyman insider trades
Open-market stock purchases and sales by Barbara Leyman, Chief Business Officer at Sutro Biopharma, Inc, from SEC Form 4 filings since Jul 8, 2024.
Recent trades
No open-market trades in the last 12 months.
Companies traded
- STRO Sutro Biopharma, Inc: other filings, last Jul 8, 2025